About Quanticel
The Quanticel team combines a veteran management team, leading academics from Stanford University, and astute VC investors from Versant Ventures.
Learn MoreScience and Technology
Quanticel's proprietary platform for single-cell genomic analysis of tumors supports the discovery of first-in-class oncology drug candidates.
Learn MoreNews
Quanticel is engaged in a R&D collaboration with Celgene Corporation in which Quanticel will identify predictive biomarkers for Celgene’s drugs and develop novel oncology products.
Learn MoreCareers
Quanticel is currently hiring exceptional researchers and technical experts committed to advancing our capabilities and, ultimately, improving patients’ lives.
Learn More